MIMEDX GROUP, INC. Logo

MIMEDX GROUP, INC.

Provides placental-based biologics for advanced wound care, surgical, and burn applications.

MDXG | US

Overview

Corporate Details

ISIN(s):
US6024961012
LEI:
Country:
United States of America
Address:
1775 W OAK COMMONS COURT, NE, 30062 MARIETTA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

MIMEDX GROUP, INC. is a therapeutic biologics company specializing in placental-based technologies. The company develops and distributes human placental tissue allografts for applications in advanced wound care, surgical recovery, and burn treatment. As a pioneer in the field, its portfolio of products is supported by extensive clinical and scientific evidence, with over 50 publications. MIMEDX targets healthcare professionals and aims to improve patient outcomes by providing innovative healing solutions and comprehensive reimbursement support services to ensure broad patient access across the United States.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all MIMEDX GROUP, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MIMEDX GROUP, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MIMEDX GROUP, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Global provider of medical aesthetic solutions like botulinum toxin and HA fillers.
South Korea 145020
Humacyte, Inc. Logo
Bioengineering off-the-shelf human tissues for vascular repair and regenerative medicine.
United States of America HUMA
Human Stem Cells Institute PJSC Logo
A biotech investor developing gene therapy, regenerative medicine, and genetic services.
Russian Federation ISKJ
HUMASIS CO., LTD. Logo
Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.
South Korea 205470
Humedix Co., Ltd. Logo
Develops hyaluronic acid-based pharma, aesthetics, medical devices, and offers CMO services.
South Korea 200670
HUONS CO., LTD. Logo
Global healthcare company providing pharmaceuticals, medical devices, and wellness products.
South Korea 243070
Huons Global Co., Ltd. Logo
Develops pharmaceuticals, medical devices, cosmetics, and health foods for the global market.
South Korea 084110
Hong Kong HCM
HWAIL PHARM. CO., LTD Logo
Develops and manufactures APIs, finished drugs, and functional ingredients for healthcare.
South Korea 061250
Hyloris Pharmaceuticals SA Logo
A biopharma company optimizing existing drugs for unmet needs via abbreviated pathways.
Belgium HYL

Talk to a Data Expert

Have a question? We'll get back to you promptly.